Risk factors for vascular disease and dementia

Haemostasis

Volumn 28, Issue 3-4, 1998, Pages 167-173

  Breteler, Monique M B ^a   Bots, Michiel L ^a,b   Ott, Alewijn ^a,c   Hofman, Albert ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alcohol; Alzheimer's disease; Atherosclerosis; Atrial fibrillation; Cholesterol; Dementia; Diabetes; Smoking; Socioeconomic status; Vascular factor

Indexed keywords

CHOLESTEROL; HOMOCYSTEINE;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; CHOLESTEROL METABOLISM; HEART ATRIUM FIBRILLATION; HUMAN; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOCIAL STATUS; STROKE;

EID: 0032468013     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022428     Document Type: Article

References (57)

1. Breteler MMB, Claus JJ, Grobbee DE, Hofman A: Cardiovascular disease and the distribution of cognitive function in an elderly population. The Rotterdam Study. BMJ 1994;308:1604-1608.
2. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, Van Duijn CM, Van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein-E and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-154.
3. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-817.
4. Breteler MMB, Claus JJ, Launer LJ, van Duijn CM, Hofman A: Epidemiology of Alzheimer's disease. Epidemiol Rev 1992;14:59-82.
5. van Duijn CM: Epidemiology of the dementias: Recent developments and new approaches. J Neurol Neurosurg Psychiatry 1996;60:478-488.
6. Ott A, Breteler MMB, Van Harskamp F, Stijnen T, Hofman A: The incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998;147:574-580.
7. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B: Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology 1997;48:132-138.
8. Boysen G, Nyboe J, Appleyard M, Sorensen PS, Boas J, Somnier F, Jensen G, Schnohr P: Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 1988;19:1345-1353.
9. Katzman R: Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:13-20.
10. Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A: Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam Study. BMJ 1995;310:970-973.
11. Beard CM, Kokmen E, Offord KP, Kurland LT: Lack of association between Alzheimer's disease and education, occupation, marital status, or living arrangement. Neurology 1992;42:2063-2068.
12. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB: The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995;45:1707-1712.
13. Ott A: Risk of dementia: The Rotterdam Study; Thesis, Erasmus University, Rotterdam, 1997, pp 49-61.
14. Bucht G, Adolfsson R, Lithner R, Winblad B: Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 1983;213:387-392.
15. Landin K, Blennow K, Wallin A, Gottfries CG: Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder? J Intern Med 1993;233:357-363.
16. Mortel KF, Wood S, Pavol MA, Meyer JS, Rexer JL: Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease. Angiology 1993;44:599-605.
17. Nielson KA, Nolan JH, Brechtold NC, Sandman CA, Mulnard RA, Cotman CW: Apolipoprotein-E genotyping of diabetic dementia patients: Is diabetes rare in Alzheimer's disease? J Am Geriatr Soc 1996;44:897-904.
18. Wolf-Klein GP, Siverstone FA, Brod MS, Levy A, Foley CJ, Termotto V, Breuer J: Are Alzheimer patients healthier? J Am Geriatr Soc 1988;36:219-224.
19. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB: Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 1996;39:1392-1397.
20. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ: Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am J Epidemiol 1997;145:301-308.
21. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 1995;45:1161-1168.
22. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
23. Kuusisto J, Mykkänen L, Pyörälä K, Laaks OM: Non insulin dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 1994;25:1157-1164.
24. Messier C, Gagnon M: Glucose regulation and cognitive functions: Relation to Alzheimer's disease and diabetes. Behav Brain Res 1996;75:1-11.
25. Anonymous: Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokers in 450,000 people in 45 prospective cohorts. Lancet 1995;346:1647-1653.
26. Gorelick PB, Schneck M, Berglund LF, Feinberg W, Goldstone J: Status of lipids as a risk factor for stroke. Neuroepidemiology 1997;16:107-115.
27. Wolf PA, Cobb JL, D'Agostino RB: Epidemiology of sroke; in Barnett HJM, Mohr JP, Stein BM, et al. (eds): Stroke: Pathophysiology, Diagnosis, and Management, ed 2. New York, Churchill-Livingstone, 1992.
28. Giubilei F, D'Antona R, Antonini R, Lenzi GL, Ricci G, Fieschi C: Serum lipoprotein pattern variations in dementia and ischemic stroke. Acta Neural Scand 1990;81:84-86.
29. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB: Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study. Neurology 1995;45:1092-1096.
30. Bartecchi CE, MacKenzie TD, Schrier RW: The human costs of tobacco use (1). N Engl J Med 1994;330;907-912.
31. Shinton R, Beevers G: Meta-analysis of the relation between cigarette smoking and stroke. BMJ 1989;298:789-794.
32. Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, et al: Alcohol and tobacco consumption as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991;20(suppl 2):S48-S57.
33. Anonymous: The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.
34. Forster DP, Newens AJ, Kay DW, Edwardson JA: Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: A casecontrol study in northern England. J Epidemiol Community Health 1995;49:253-258.
35. Hebert LE, Scherr PA, Beckett LA, Funkenstein HH, Albert MS, Chown MJ, Evans DA: Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol 1992;135:347-355.
36. Brenner DE, Kukull WA, van Belle G, et al: Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993;43:293-300.
37. Letenneur L, Dartigues JF, Commenges D, Burberger-Gateau P, Tessier JF, Orgogozo JM: Tobacco consumption and cognitive impairment in elderly people. A population-based study. Ann Epidemiol 1994;4:449-454.
38. Prince M, Cullen M, Mann A: Risk factors for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology 1994;44:97-104.
39. Newhouse PA, Potter A, Corwin J, Lenox R: Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology 1994;10:93-107.
40. Nitta A, Katono Y, Itoh A, Hasegawa T, Nabeshima T: Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system. Pharmacol Biochem Behav 1994;49:807-812.
41. Riggs JE: Smoking and Alzheimer's disease: Protective effect or differential survival bias? Lancet 1993;342:793-794.
42. Ott A, Slooter AJC, Hofman A, van Harskamp F, Witteman JCM, van Broeckhoven C, van Duijn CM, Breteler MMB: Smoking and the risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam Study. Lancet 1998;351:1840-1843.
43. van Duijn CM, Havekes LM, Van Broeckhoven C, De Knijff P, Hofman A: Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ 1995;310:627-631.
44. Poirier J, Delisle M-C, Quirion R, et al: Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995;92:12260-12264.
45. Jamrozik K, Phil D, Broadhurst J, Anderson CS, Stewart-Wynne E: The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia. Stroke 1994;25:51-59.
46. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH: A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:267-273.
47. Fratiglioni L, Ahlbom A, Viitanen M, Winblad B: Risk factors for late-onset Alzheimer's disease: A population-based, case-control study. Ann Neurol 1993;33:258-266.
48. Saunders PA, Copeland JR, Dewey ME, Davidson IA, McWilliam C, Sharma V, Sullivan C: Heavy drinking as a risk factor for depression and dementia in elderly men. Finding from the Liverpool longitudinal study. Br J Psychiatry 1991;159:213-216.
49. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, Renaud S, Breteler MMB: Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area. Rev Neurol (Paris) 1997;153:185-192.
50. Breteler MMB, Mehta K, Ott A, Witteman JCM, Hofman A: Alcohol consumption and dementia. The Rotterdam Study (abstract). J Neurol 1997;244(suppl 3):S47.
51. Kannel WB, Wolf PA, Verier J: Manifestation of coronary disease predisposing to stroke. The Framingham Study. JAMA 1983;250:2942-2946.
52. Norris JW, Zhu CZ, Bornstein NM, Chambers BR: Vascular risk of asymptomatic carotid stenosis. Stroke 1991;22:1485-1490.
53. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, Thadani V, Meyer ML, Bridgers SL: Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 1995;92:2178-2182.
54. Peterson P: Thromboembolic complications in atrial fibrillation. Stroke 1990;21:4-13.
55. Anonymous: Cardiogenic dementia. Lancet 1977;i:27-28.
56. Ott A, Breteler MMB, De Bruyne MC, Van Harskamp F, Grobbee DE, Hofman A: Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997;28:316-321.
57. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB: Probability of stroke: A risk profile from the Framingham Study. Stroke 1991;22:312-318.